MyHealthChecked PLC Statement re. DHSC press release
24 Agosto 2021 - 3:00AM
RNS Non-Regulatory
TIDMMHC
MyHealthChecked PLC
24 August 2021
MyHealthChecked plc
( " MyHealthChecked " or " the Company " )
Statement re. DHSC press release
MyHealthChecked welcomes further scrutiny of private testing
companies
MyHealthChecked Plc (AIM: MHC), the consumer home-testing
healthcare company, welcomes the announcement yesterday from the
Department of Health and Social Care ("DHSC") that private COVID-19
testing companies will be removed from the GOV.UK list if they
advertise misleading prices. 82 providers, making up around 18% of
companies listed, have been identified as displaying lower prices
on GOV.UK than are available on their website at the point of
checkout.
MyHealthChecked welcomes a greater degree of Government scrutiny
of private testing companies included on the UK Government list of
approved providers of COVID-19 testing service for travel. Not only
does MyHealthChecked provide clear, transparent and market
competitive pricing for compliant testing for international travel
tests, but also ensures a high standard of service and robust
laboratory capacity planning methods to ensure customer needs are
met.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc,
said:
"This is very good news for the public as it will only improve
the calibre of COVID-19 testing services available, and ensure
pricing is transparent whilst driving an improvement in quality of
service from those approved companies included on the Government
list. At MyHealthChecked we have always been clear on pricing. We
have made pricing information simple, the nasal swab process is
simple and our customer care is second to none, with tens of
thousands of satisfied customers as a result of our service.
"Sadly, we hear reports of other testing companies on the
Government list also falling short when it comes to maintaining
high standards across other aspects of their service and we welcome
the Health Secretary's call for the competition watchdog to
investigate concerns about inadequate service.
"We agree with the Government that only the most compliant,
reliable and efficient testing service providers should be on that
list and we take great pride that we can fulfil our obligations for
laboratory capacity, achievement of turnaround times at our labs,
and clear pricing structures across the portfolio."
MyHealthChecked's services have been included as one of the
suppliers on the Government list with "Fit to Fly", "Test to
Release" and "Days 2 and 8" testing, and the Company has
established a key commercial partnership with Boots UK Limited
("Boots") . The MyHealthChecked COVID-19 testing service is
available via www.boots.com and across over 500 Boots stores in
Great Britain.
The MyHealthChecked(TM) COVID-19 at-home nasal swab kit and PCR
laboratory testing service utilises the Company's own laboratory in
Manchester, together with its partner laboratory provided by
Yourgene Health plc. The laboratories used as part of the
MyHealthChecked(TM) COVID-19 testing service all deliver a
proficient and high-quality service.
The full DHSC announcement can be seen here:
https://www.gov.uk/government/news/82-testing-providers-to-be-issued-warnings-over-misleading-prices
For further information contact:
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick , Chief Executive via Walbrook PR
Officer
Gareth Davies, Chief Financial and
Operations Officer
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media & Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
IR)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407
804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests, now in development following the acquisition of The
Genome Store in November 2020. The tests will be made available
online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
About RNS Reach announcements
RNS Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases such as
marketing messages, corporate and product information into the
public domain. An RNS Regulatory announcement is required to be
notified under the AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUOUARAVUWUUR
(END) Dow Jones Newswires
August 24, 2021 02:00 ET (06:00 GMT)
Myhealthchecked (LSE:MHC)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Myhealthchecked (LSE:MHC)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024